Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

76.91

-1.13 (-1.45%)

Jan 2, 2026, 11:49 AM EST - Market open

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Jan '26 Jan 2, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2019 - 2020
Market Capitalization	627	429	5	6	20	85	Upgrade
Market Cap Growth	13411.48%	8742.00%	-18.98%	-70.74%	-75.79%	-	Upgrade
Enterprise Value	567	393	0	0	14	67	Upgrade
Last Close Price	78.04	60.66	1.17	1.60	6.15	35.71	Upgrade
PB Ratio	10.65	7.29	1.19	1.23	2.67	5.51	Upgrade
P/TBV Ratio	10.65	7.29	1.19	1.23	2.67	5.52	Upgrade
Debt / Equity Ratio	0.00	0.00	0.02	0.01	0.01	-	Upgrade
Quick Ratio	35.68	35.68	10.92	24.16	8.00	31.12	Upgrade
Current Ratio	36.10	36.10	11.32	24.26	8.11	31.38	Upgrade
Return on Equity (ROE)	-27.93%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%	Upgrade
Return on Assets (ROA)	-18.80%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%	Upgrade
Return on Capital (ROIC)	-19.38%	-19.38%	-26.62%	-51.86%	-61.21%	-53.54%	Upgrade
Return on Capital Employed (ROCE)	-16.60%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%	Upgrade
Earnings Yield	-1.40%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%	Upgrade
Buyback Yield / Dilution	-59.58%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q